$CERS
Cerus Corp Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000119312514192903 Filed on May 12, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$7.866M	$9.733M
YoY Change	-19.18%	11.99%
Cost Of Revenue	$4.157M	$5.090M
YoY Change	-18.33%	-7.69%
Gross Profit	$3.709M	$4.643M
YoY Change	-20.12%	46.14%
Gross Profit Margin	47.15%	47.7%
Selling, General & Admin	$8.236M	$6.853M
YoY Change	20.18%	14.87%
% of Gross Profit	222.05%	147.6%
Research & Development	$4.642M	$2.700M
YoY Change	71.93%	48.03%
% of Gross Profit	125.16%	58.15%
Depreciation & Amortization	$325.0K	$167.0K
YoY Change	94.61%	-19.71%
% of Gross Profit	8.76%	3.6%
Operating Expenses	$12.93M	$9.603M
YoY Change	34.62%	22.49%
Operating Profit	-$9.219M	-$4.960M
YoY Change	85.87%	8.49%
Interest Expense	$50.00K	$131.0K
YoY Change	-61.83%	-5.76%
% of Operating Profit
Other Income/Expense, Net	$9.032M	-$5.241M
YoY Change	-272.33%	23.99%
Pretax Income	-$187.0K	-$10.20M
YoY Change	-98.17%	15.93%
Income Tax	$38.00K	$51.00K
% Of Pretax Income
Net Earnings	-$225.0K	-$10.25M
YoY Change	-97.81%	16.05%
Net Earnings / Revenue	-2.86%	-105.33%
Basic Earnings Per Share	$0.00	-$0.17
Diluted Earnings Per Share	-$0.12	-$0.17
COMMON SHARES
Basic Shares Outstanding	72.09M shares	59.73M shares
Diluted Shares Outstanding	75.16M shares	59.73M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.30M	$69.20M
YoY Change	-30.2%	119.68%
Cash & Equivalents	$23.99M	$69.16M
Short-Term Investments	$24.30M
Other Short-Term Assets	$913.0K	$418.0K
YoY Change	118.42%	-62.0%
Inventory	$11.31M	$11.76M
Prepaid Expenses	$1.661M	$1.370M
Receivables	$4.943M	$4.733M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$67.08M	$87.44M
YoY Change	-23.29%	87.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.166M	$1.595M
YoY Change	98.5%	-16.05%
Goodwill	$1.316M	$1.316M
YoY Change	0.0%
Intangibles	$1.294M	$1.496M
YoY Change	-13.5%
Long-Term Investments
YoY Change
Other Assets	$64.00K	$58.00K
YoY Change	10.34%	-88.4%
Total Long-Term Assets	$6.148M	$4.767M
YoY Change	28.97%	-11.72%
TOTAL ASSETS
Total Short-Term Assets	$67.08M	$87.44M
Total Long-Term Assets	$6.148M	$4.767M
Total Assets	$73.23M	$92.21M
YoY Change	-20.58%	77.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.493M	$3.887M
YoY Change	-10.14%	-7.45%
Accrued Expenses	$8.838M	$8.149M
YoY Change	8.46%	8.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.300M	$4.500M
YoY Change	-26.67%	45.16%
Total Short-Term Liabilities	$27.23M	$27.66M
YoY Change	-1.53%	0.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$2.500M
YoY Change	-100.0%	-39.02%
Other Long-Term Liabilities	$1.031M	$1.209M
YoY Change	-14.72%	0.75%
Total Long-Term Liabilities	$1.031M	$1.209M
YoY Change	-14.72%	-77.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.23M	$27.66M
Total Long-Term Liabilities	$1.031M	$1.209M
Total Liabilities	$28.36M	$31.42M
YoY Change	-9.74%	-3.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$503.4M	-$470.1M
YoY Change	7.09%
Common Stock	$72.00K	$70.00K
YoY Change	2.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$44.87M	$60.79M
YoY Change
Total Liabilities & Shareholders Equity	$73.23M	$92.21M
YoY Change	-20.58%	77.32%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$225.0K	-$10.25M
YoY Change	-97.81%	16.05%
Depreciation, Depletion And Amortization	$325.0K	$167.0K
YoY Change	94.61%	-19.71%
Cash From Operating Activities	-$9.830M	-$8.352M
YoY Change	17.7%	113.93%
INVESTING ACTIVITIES
Capital Expenditures	$839.0K	-$30.00K
YoY Change	-2896.67%
Acquisitions
YoY Change
Other Investing Activities	$460.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$3.000M	-$26.00K
YoY Change	-11638.46%	-113.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$31.00K	$51.50M
YoY Change	-99.94%	435.81%
Debt Paid & Issued, Net	$125.0K
YoY Change
Cash From Financing Activities	1.330M	50.85M
YoY Change	-97.38%	426.35%
NET CHANGE
Cash From Operating Activities	-9.830M	-8.352M
Cash From Investing Activities	3.000M	-26.00K
Cash From Financing Activities	1.330M	50.85M
Net Change In Cash	-5.500M	42.47M
YoY Change	-112.95%	613.49%
FREE CASH FLOW
Cash From Operating Activities	-$9.830M	-$8.352M
Capital Expenditures	$839.0K	-$30.00K
Free Cash Flow	-$10.67M	-$8.322M
YoY Change	28.2%	113.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	72513000	shares
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69163000
CY2014Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18100000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.00
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12208000	shares
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	27234000
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7000
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1899000
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1410000
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	548202000
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3493000
CY2014Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2995000
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11356000
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1031000
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	44867000
CY2014Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	11356000
CY2014Q1	us-gaap	Liabilities Liabilities	28360000
CY2014Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	3268000
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-503414000
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	279000
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8838000
CY2014Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	11356000
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	33911000
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	33911000
CY2014Q1	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	11307000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	913000
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2142000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2014Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3300000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	723000
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	72000
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73227000
CY2014Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	95000
CY2014Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	64000
CY2014Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	24263000
CY2014Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1661000
CY2014Q1	us-gaap	Goodwill Goodwill	1316000
CY2014Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	33903000
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	33903000
CY2014Q1	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	308000
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1294000
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4943000
CY2014Q1	us-gaap	Inventory Net InventoryNet	11307000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9165000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	150000
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3166000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2014Q1	us-gaap	Assets Assets	73227000
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23992000
CY2014Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1294000
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	33911000
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	33903000
CY2014Q1	us-gaap	Assets Current AssetsCurrent	67079000
CY2014Q1	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3268000
CY2014Q1	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	200000
CY2014Q1	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	0
CY2014Q1	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	0
CY2014Q1	cers	Leasehold Improvement Reflected In Other Non Current Liabilities LeaseholdImprovementReflectedInOtherNonCurrentLiabilities	600000
CY2014Q1	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2189000
CY2013Q4	us-gaap	Assets Assets	83381000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1344000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	30700000
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	308000
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1344000
CY2014Q1	cers	Accrued Inventory AccruedInventory	2534000
CY2014Q1	cers	Leasehold Improvement Reflected In Accrued Liabilities LeaseholdImprovementReflectedInAccruedLiabilities	100000
CY2014Q1	cers	Outstanding Liability Related To Leasehold Improvements Current And Non Current OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent	700000
CY2014Q1	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	3	Customer
CY2014Q1	cers	Options And Other Stock Based Awards OptionsAndOtherStockBasedAwards	12300000	shares
CY2014Q1	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	0
CY2014Q1	cers	Performance Based Stock Options Outstanding PerformanceBasedStockOptionsOutstanding	50000	shares
CY2014Q1	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	0
CY2014Q1	cers	Finite Lived Intangible Assets Amortization Expense Year Seven FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven	100000
CY2014Q1	cers	Available For Sale Securities Gross Unrealized Gain Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainLossAccumulatedInInvestments	8000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26696000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10405000	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39424000
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7000
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2527000
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1011000
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545905000
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5674000
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2722000
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	20390000
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1073000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	42795000
CY2013Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20390000
CY2013Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3366000
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-503189000
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	181000
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9813000
CY2013Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	20390000
CY2013Q4	us-gaap	Liabilities Liabilities	40586000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	673000
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	72000
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83381000
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	89000
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28191000
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	848000
CY2013Q4	us-gaap	Goodwill Goodwill	1316000
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	36834000
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6125000
CY2013Q4	us-gaap	Inventory Net InventoryNet	13063000
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8200000
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	36841000
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	442000
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4863000
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	36841000
CY2013Q4	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	13063000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	30701000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	36834000
CY2013Q4	us-gaap	Assets Current AssetsCurrent	78154000
CY2013Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3366000
CY2013Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	0
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	6134000
CY2013Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2013Q4	cers	Accrued Inventory AccruedInventory	3553000
CY2013Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2013Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	0
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	6140000
CY2013Q4	cers	Available For Sale Securities Gross Unrealized Gain Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainLossAccumulatedInInvestments	7000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59730000	shares
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15531000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59730000	shares
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-910000
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9733000
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10252000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10201000
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	289000
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-54000
CY2013Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	1335000
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10252000
CY2013Q1	us-gaap	Gross Profit GrossProfit	4643000
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4000
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4960000
CY2013Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	26000
CY2013Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-56000
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5241000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-10252000
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1624000
CY2013Q1	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2014Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2013Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-26000
CY2013Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5090000
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7000
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	713000
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	42467000
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	9603000
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6853000
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51000
CY2013Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	50845000
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	97000
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	85000
CY2013Q1	us-gaap	Interest Expense InterestExpense	131000
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3299000
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	51502000
CY2013Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	2700000
CY2013Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	526000
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	167000
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2013Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-8352000
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	713000
CY2013Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2013Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	152000
CY2013Q1	cers	Foreign Currency Exchange Gain Loss ForeignCurrencyExchangeGainLoss	-100000
CY2013Q1	cers	Performance Based Stock Options Awards PerformanceBasedStockOptionsAwards	0
CY2013Q1	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	-5073000
CY2013Q1	cers	Payment For Royalty PaymentForRoyalty	800000
CY2013Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	3900000
CY2014Q1	dei	Trading Symbol TradingSymbol	CERS
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.49
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.78
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	30000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75158000	shares
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3070000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.20
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	478000	shares
CY2014Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and short-term investments are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At March 31, 2014, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Concentrations of credit risk with respect to trade receivables exist. However, in connection with the Company’s revolving line of credit, as discussed in Note 8 in the Notes to Condensed Consolidated Financial Statements, the Company purchased a credit insurance policy that mitigates some of its credit risk, as the policy will pay either the Company or its lender on eligible claims filed on its outstanding receivables. On a regular basis, including at the time of sale, the Company performs credit evaluations of its customers. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company reserves against the accounts receivable on its condensed consolidated balance sheets and records a charge on its condensed consolidated statements of operations. At March 31, 2014 and December 31, 2013, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> The Company had three customers and two customers that accounted for more than 10% of the Company’s outstanding trade receivables at March 31, 2014, and December 31, 2013, respectively. These customers cumulatively represented approximately 65% and 55% of the Company’s outstanding trade receivables at March 31, 2014, and December 31, 2013, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
CY2014Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	36000	shares
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16901000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.65
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2347000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72088000	shares
CY2014Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2014Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2014Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company after December 31, 2002. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable.</p> </div>
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-9034000
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	764000
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	460000
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7866000
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	170000
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9259000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-187000
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1182000
CY2014Q1	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	21000
CY2014Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	125000
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-225000
CY2014Q1	us-gaap	Gross Profit GrossProfit	3709000
CY2014Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9219000
CY2014Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	2700000
CY2014Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	839000
CY2014Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2014Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0
CY2014Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1425000
CY2014Q1	cers	Foreign Currency Exchange Gain Loss ForeignCurrencyExchangeGainLoss	100000
CY2014Q1	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
CY2014Q1	cers	Performance Based Stock Options Awards PerformanceBasedStockOptionsAwards	0
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2014Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-9825000
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	945000
CY2014Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q1	cers	Prior Written Notice Period For Termination Of Agreement PriorWrittenNoticePeriodForTerminationOfAgreement	P24M
CY2014Q1	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	9034000
CY2014Q1	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9032000
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-225000
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1117000
CY2014Q1	us-gaap	Dilutive Securities DilutiveSecurities	-9034000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2014Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	3001000
CY2014Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4157000
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	946000
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5493000
CY2014Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4300000
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	12928000
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8236000
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000
CY2014Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	1331000
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	98000
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1295000
CY2014Q1	us-gaap	Interest Expense InterestExpense	193000
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2181000
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31000
CY2014Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4642000
CY2014Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325000
CY2014Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2014Q1	cers	Payment For Royalty PaymentForRoyalty	700000
CY2014Q1	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
CY2014Q1	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
CY2014Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4600000
CY2014Q1	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
CY2014Q1	cers	Eligible To Receive Royalty Fee EligibleToReceiveRoyaltyFee	0.01	pure

Files In Submission

Name	View Source	Status
0001193125-14-192903-index-headers.html	Edgar Link	pending
0001193125-14-192903-index.html	Edgar Link	pending
0001193125-14-192903.txt	Edgar Link	pending
0001193125-14-192903-xbrl.zip	Edgar Link	pending
cers-20140331.xml	Edgar Link	completed
cers-20140331.xsd	Edgar Link	pending
cers-20140331_cal.xml	Edgar Link	unprocessable
cers-20140331_def.xml	Edgar Link	unprocessable
cers-20140331_lab.xml	Edgar Link	unprocessable
cers-20140331_pre.xml	Edgar Link	unprocessable
d696866d10q.htm	Edgar Link	pending
d696866dex102.htm	Edgar Link	pending
d696866dex103.htm	Edgar Link	pending
d696866dex104.htm	Edgar Link	pending
d696866dex311.htm	Edgar Link	pending
d696866dex312.htm	Edgar Link	pending
d696866dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g696866ex10_27pg0012.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
Cerus Corp Stock $cers

2014 Q1 Form 10-Q Financial Statement

#000119312514192903 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS Cerus Corp Stock $cers

2014 Q1 Form 10-Q Financial Statement

#000119312514192903 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
Cerus Corp Stock $cers